Header cover image

Brazilian Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED May 22, 2022

Companies with a Value score of at least 3, ordered by Value score

12 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
I1NC34IncyteR$188.870%n/aR$16.6bR$233.16PS17.8xE27.7%n/a
E2XE34ExelixisR$42.66-16.7%n/aR$5.7bR$63.73PS19.1xE24.7%n/a
BLAU3Blau FarmacĂȘuticaR$23.500.8%-44.6%R$4.2bR$41.67PS14xE17.5%1.1%
H1ZN34Horizon TherapeuticsR$43.86-3.6%-12.6%R$20.8bR$69.05PS24.1xE27.7%n/a
ABBV34AbbVieR$733.60-5.5%18.2%R$266.9bR$802.93PS21.5xE-0.3%3.7%
GILD34Gilead SciencesR$154.87-0.9%-16.1%R$80.1bR$169.97PS17.7xE8.4%4.6%
PFIZ34PfizerR$63.691.6%19.1%R$294.4bR$70.14PS11.6xE-17.1%3.0%
REGN34Regeneron PharmaceuticalsR$639.87-2.0%17.4%R$71.2bR$667.17PS9xE-3.9%n/a
MRCK34MerckR$56.79-0.6%7.2%R$236.6bR$58.30PS17xE13.0%2.9%
AMGN34AmgenR$42.91-1.7%-10.7%R$132.2bR$42.75PS23.1xE10.7%3.1%
BIIB34BiogenR$161.34-3.3%-36.7%R$29.2bR$198.68PS20.2xE2.2%n/a
C2RS34CRISPR TherapeuticsR$32.6212.8%n/aR$4.4bR$69.85PS14xE57.9%n/a
Page 1 of 1